Submissions from 2026
Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial, Maen Abdelrahim, Gazala Khan, Hassan Hatoum, Alice Zervoudakis, Farshid Dayyani, Li Zhang, Jia Li, Fiona Maxwell, Eileen M O'Reilly, Zev A Wainberg, and Andrea Bullock
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications, Can Aydogdu, Laura Bukavina, Liang Cheng, Hikmat A Al-Ahmadie, Omar Alhalabi, Jason R Brown, Antonio Lopez-Beltran, Petros Grivas, Clara Hwang, G Daniel Grass, Ashish M Kamat, Jonathan Chatzkel, Omar Mian, Andrea Necchi, Jeff Ross, Andrea B Apolo, Philippe E Spiess, and Roger Li
Daraxonrasib in pancreatic cancer: When progress disrupts practice, Asfar S. Azmi and Philip A. Philip
Malignant ascites as an immune organ and implications for cancer immunotherapy, Dmitry D Basov, Matthew J. Dorman, Kyle A Burton, Anastasia E Metropulos, Hidayatullah G Munshi, and Daniel R Principe
Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced NSCLC in a Phase 2 Study, Todd M Bauer, Jean-François Martini, Benjamin Besse, Chia-Chi Lin, Ross A Soo, Gregory J Riely, I-Ming Wang, Francesca Toffalorio, Deborah A Shepard, Tiziana Usari, Phineas Hamilton, D Ross Camidge, Steven Kao, Rita Chiari, Shirish M. Gadgeel, Enriqueta Felip, Alice T Shaw, and Benjamin J Solomon
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer, Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano, Daniel W Bowles, Robert C Doebele, Aaron S Mansfield, Christina S Baik, Gilberto de Lima Lopes, Luis Paz-Ares, Matthew H Taylor, Daniel S W Tan, Guzman Alonso, Shirish M. Gadgeel, Gregory P Kalemkerian, Sai-Hong Ignatius Ou, Anthonie J van der Wekken, Carlos R Becerra, Makenzi Evangelist, Frank Griesinger, Stephen V Liu, Yanyan Lou, Julien Mazières, Jason M Melear, Mohit Narang, Ashish Saxena, Michael Thomas, Sophia Wang, Amber Thomassen, Dae Ho Lee, Dong-Wan Kim, and Justin F Gainor
Endoscopic Ultrasound-Guided Franseen Fine-Needle Biopsy for Solid Pancreatic Lesions: A Systematic Review and Meta-Analysis, Adnan Bhat, Muhammad Arham, Zahra Ali, Saniya Ishtiaq, Muhammad Abdul Rehman, Adil Ahmed, Anchit Chauhan, Haseeb K. Tareen, Kinza Bakht, Faseeh Haider, Allah Dad, Lindsey Creech, Aleksey Novikov, and Peter V Draganov
HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results, David A Braun, Marcus S Noel, Ryan H Moy, Kurt Demel, Martin Gutierrez, Sunil Sharma, Arif Hussain, Shirish M. Gadgeel, Julio Peguero, Toni K Choueiri, Hamid Emamekhoo, Brian Van Tine, Rama Balaraman, GiNell Elliott, Sritama Nath, Scott R Daigle, Pavan Kumar, Anita Scheuber, and David Sommerhalder
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium, Alaina J Brown, Chih-Yuan Hsu, Aleenah Mohsin, Lauren S Prescott, Alicia Beeghly, Erika Ruiz-Garcia, Diana Vilar-Compte, José Antonio García-Gordillo, Clara Hwang, Miriana Hijaz, Thomas Buekers, Sunny R. K Singh, Trisha M Wise-Draper, Elizabeth K Ferrara, Rana R McKay, Archana Ajmera, Melissa Mariano, Padmanabh Bhatt, Gayathri Nagaraj, Matthew Puc, Jonathan A Cosin, Babar Bashir, Karen Russell, Susan Halabi, Hannah McManus, Melissa K Accordino, Blanche H Mavromatis, Monika Joshi, Hyma V Polimera, Salvatore A Del Prete, Suzanne J Rose, Suki Subbiah, Bryan A Faller, Abdul Hai Mansoor, Marc Eid, Sanjay Mishra, Roisin E O'Cearbhaill, Marta A Crispens, Yu Shyr, and Jeremy L Warner
Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population, Khalil Choucair, Hayat Bazzi, Faten Abda, Farah Harb, Yasmin Snounu, Vy Ong, Wei Chen, Colin Barton, Hirva Mamdani, Shirish M. Gadgeel, and Morhaf Al Achkar
Advancing systemic therapy for biliary tract cancer: current strategies and emerging paradigms, Khalil Choucair, Shadi Chamseddine, Asfar Azmi, and Philip A. Philip
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer, Toni K Choueiri, Jaime Merchán, Amita Patnaik, Alexandra Drakaki, Brian I Rini, Sun Young Rha, Jae Lyun Lee, Moshe C Ornstein, Rohit Kumar, Clara Hwang, Yusra Shao, Se Hoon Park, Pedro C Barata, Bradley A McGregor, Paul Foster, Jianfen Chen, Melissa Eisen, Hunter Cole, Ben Weeder, Yinghui Guan, Jaskirat Singh, Angelo Kaplan, Soonweng Cho, Richard Markus, Omar Kabbarah, and Rana R McKay
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study, Tammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, Lauren E Amos, Meera Chitlur, Nabil Daoud, Ashley Eason, Miguel Escobar, Carol Fedor, Shveta Gupta, Philip Kuriakose, Sonia Nasr, Sharon Pennington, Rajiv K Pruthi, Michael Recht, Andreana Robertson, Doris V Quon, Allison P Wheeler, and Mark Reding
Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity, Jacqueline G Clarke, Naibedya Dutta, Matthew S Nickel, Zhang Wang, Juri Kim, Joseph Media, David A Coppage, Erin P McCauley, Joe A Gerke, Marc O Anderson, Ryo Higuchi-Sanabria, Frederick A. Valeriote, Phillip Crews, and Tyler A Johnson
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence, Sebastian Cole, Paul Campitelli, Brian Grieb, Igor Astsaturov, Daniel Von Hoff, Harshabad Singh, Michael J Pishvaian, Tanios S Bekaii-Saab, Peter J Hosein, Philip A. Philip, Anthony Helmstetter, Todd Maney, Jennifer R Ribeiro, James Hamrick, Daniel Magee, and David Spetzler
Platanosides, a Promising Class of Plant-Derived Antibiotics, Are Effective against a Suite of Clinically Derived MDR and Drug-Sensitive Staph and Strep spp, Cody F Dickinson, Menny M Benjamin, Ahmed Alford, Hope L Moreno, Geehan Suleyman, Maryssa Trupiano, Britney Aldrich, Frederick A. Valeriote, Nicolas Arosemena, Lucas Bialousow, Ron Benjamin, Zhi Zhong, Marcus A Tius, Yeun-Mun Choo, John J Lemasters, and Mark T Hamann
Role of FMS-Like Tyrosine Kinase 3 (FLT3) Inhibitors in a Patient With T/Myeloid Acute Leukemia With an FLT3 Mutation, Nicholas Elias, Ahsun R. Siddiqi, Talal Bazzi, and Daniel Lebovic
A human model of progressive pancreatic neoplasia and cancer, David Escobar Flores and Howard C. Crawford
Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025, Narjust Florez, Sandip Pravin Patel, Ravi Salgia, Jacob Sands, Erin L Schenk, Elaine Shum, Mihaela Aldea, Christine M Bestvina, Jessica Donington, Christine A Garcia, Jorge Nieva, David R Gandara, Balazs Halmos, Fred R Hirsch, Xiuning Le, Percy Lee, Jyoti Malhotra, Tejas Patil, Solange Peters, Jonathan Wesley Riess, Julia Rotow, Fawzi Abu Rous, Joshua Sabari, Triparna Sen, Eric K Singhi, Ana I Velázquez, Heather A Wakelee, and Edward S Kim
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC), Shirish M. Gadgeel, Misako Nagasaka, Karen Dziubek, Thomas Braun, Khaled Hassan, Haiying Cheng, Balazs Halmos, Antoinette Wozniak, James Stevenson, Pradnya Patil, Nathan Pennell, Mary Jo Fidler, Angel Qin, Zeqi Niu, Sunitha Nagrath, and Gregory P Kalemkerian
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease, Ashish O Gupta, Akshay Sharma, Haydar Frangoul, Julie Kanter, Markus Y Mapara, Jignesh Dalal, Asif Alavi, Jennifer J Jaroscak, Ernesto Ayala, John F DiPersio, Edward D Ziga, Mary Eapen, Stacey Rifkin-Zenenberg, Alex C Minella, Yinzhong Chen, Sarah Chesler, Srikanth Ambati, Thomas S Bowman, Bahru Habtemariam, Marcelyne Joseney-Antoine, Priya S Chockalingam, Ling Lin, Sunita Goyal, Amy Simon, Alexis A Thompson, and Matthew M Heeney
Leukemia Cutis Exhibiting the Koebner Phenomenon: A Rare Clinical Presentation of Acute Myeloid Leukemia, Megan Hauptman, Joseph S Durgin, Ahmad Mattour, Shatha Farhan, Mio Nakamura, and Michael Goldfarb
Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer, Chunbo He, Dezhen Wang, Tuo Hu, Daisy Gonzalez, Ravi Thakur, Damian P Matysniak, Ryan J King, Sai Sundeep Kollala, Spas Dimitrov Markov, Yuki Fujii, Gullanki Naga Venkata Charan Tej, Junzhang Zhao, Longyang Jin, Rebecca Oberley-Deegan, Surendra K Shukla, Xin A Zhang, Jacob E Friedman, Pankaj K Singh, Michael A Hollingsworth, Marina Pasca di Magliano, Howard C. Crawford, and Kamiya Mehla
A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling, Natalie K Horvat, Maria Diab, Maggie J Phillips, Ashley McCook-Veal, Erin E Grundy, Olatunji B Alese, Emily Greene, Olumide Gbolahan, Kathleen Coleman, Deon Doxie, Cameron J Herting, Jacklyn Hammons, Zaid Mahdi, Jeffrey M Switchenko, Chrystal M Paulos, Bassel F El-Rayes, and Gregory B Lesinski
Systemic therapies in prostate cancer: A field in transformation, Clara Hwang
Treatment and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer by Race, Initial Diagnosis, and Family History: Results From the TRUMPET Registry., Lawrence Karsh, Clara Hwang, James Symanowski, Daniel Shevrin, Dina Elsouda, David Russell, James Spalding, Pavol Kral, Nader El-Chaar, and Neal Shore
Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent, Pradeep Khanal, Suhail Sapkota, Ioannis Karageorgiou, and Tareq Al Baghdadi
XPO1 inhibition enhances the efficacy and durability of RAS-targeted therapy in preclinical models of KRASG12D mutant pancreatic ductal adenocarcinoma., Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F Bannoura, Md Hafiz Uddin, Adeeb A Aboukameel, Fulya Koksalar Alkan, Ahmet B Caglayan, Hilmi K Alkan, Bin Bao, Hugo Jimenez, Allan M Johansen, Callum McGrath, Grayson Barker, Khalil Choucair, Miguel Tobon, Eliza Beal, Steve Kim, Rafic Beydoun, Gregory Dyson, Yang Shi, Misako Nagasaka, Azeddine Atfi, Hasan Korkaya, Muhammad Wasif Saif, Philip A. Philip, Bassel El-Rayes, Herbert Chen, Anthony F Shields, Ramzi M Mohammad, Boris C Pasche, and Asfar S Azmi
Association of the endosomal TLR4 pathway with dorsolateral prostatic remodeling induced by perinatal phthalate mixture exposure in rats, Vinícius Luís Rocha da Silva Maria, Ana Clara Pacheco de Santana, Patrick Vieira Souza, Vanessa Aguiar Rocha, Matheus Naia Fioretto, Natália Magosso, Mirella Franco Moreira, Maria Clara Betete Da Silva Fonseca, André Mascarenhas Guariento, Sergio Pereira, Ariana Musa de Aquino, Letícia P Bomfim, Glaura Scantamburlo Alves Fernandes, Jodi A Flaws, Cristiane Figueiredo Pinho, and Wellerson Rodrigo Scarano
Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns, Kyle C. McElyea, James P. Purtell, Avery K. Supernois, Courtney M. Rose, Farhan Ibrahim, Mohammed Baseer, Sunita Ghosh, and Clara Hwang
Circulating Tumor DNA in Breast Cancer: Diagnostic Insights From a Case Series, Cortney McKay, Tasnim Rahman, Bipin Ghimire, and Marian R. Girgis
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers, Emily A Miao, Beow Yeap, Sameh Daher, Meghanne Lomibao, Fangdi Sun, Rachel Keogh, Jason Lambden, Amanda Reyes, Jennifer L Peterson, Joyce Liang, Audrey Liu, Andrew Do, Carrie Lee, Melinda Hsu, Makenzi Evangelist, Joshua Reuss, Shirish M. Gadgeel, Matthew Lee, Tejas Patil, Vincent Lam, Joel W Neal, Alexander Drilon, and Jessica J Lin
Reconsidering Granulocyte Infusions in Prolonged Neutropenia: A Case Report, Ananya Murali, Glenn Seela, Markie Zimmer, and Vijayalakshmi Donthireddy
Body mass index and prostate cancer incidence: a comprehensive systematic review, Dawson Myers, Daniela Chissum Lagos, Isain Zapata, and Clara Hwang
Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study, Nima Nabavizadeh, Charles McDonnell, Dax Kurbegov, Marc Matrana, Shirish M. Gadgeel, Raymond H Kim, Gretchen Stipec, Kevin C Oeffinger, Michael J Demeure, James W Lillard, Rebecca Kaltman, Jennifer Tran, Alan Roth, Sami Tahhan, Andrew Poklepovic, Donald Richards, Margarita Lopatin, Celine Marquez, Margaret McCusker, and Karthik V Giridhar
Chylous Ascites: A Rare Initial Presentation of High-Grade Follicular Lymphoma, Rama Nada, Ani Gvajaia, Ali Raza, and Mohammed Raji
Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions, Ganji Purnachandra Nagaraju, Haasita Nellipudi, Chaithanya Ganji, Vaishnavi Kuppala, Swapna Priya Ganji, Seema Kumari, Batoul Farran, Mundla Srilatha, Rachael Guenter, and Bassel F El-Rayes
A Rare Presentation of T-cell Prolymphocytic Leukemia With Abnormal Uterine Bleeding, Zeinab Nasser, Sarine Tahmazian, Moneb Bughrara, Batoul Nasser, Aula Ramo, and Vrushali Dabak
Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer, Danny Nguyen, Se-Hoon Lee, Shun Lu, Nicolas Girard, Chien-Chung Lin, Enriqueta Felip, Andres Aguilar, Chaiyut Charoentum, Felipe Melo Cruz, Hiroaki Akamatsu, Ruben Kowalyszyn, Cagatay Arslan, Martin D Forster, Damien Urban, Daniel Misch, Lizbett Vanessa García Montes, Shirish M. Gadgeel, Marcia Cruz-Correa, Scott Owen, Wolfgang Schuette, Jan Sermon, Ronja Kerßenboom, Markus Frosien, Janka Meißner, Priya Ord, Mariah Ennis, Elizabeth Fennema, Seema Sethi, Joshua M Bauml, Mahesh Daksh, and Byoung Chul Cho
Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapy, Valentín Ortiz-Maldonado, Jacques-Emmanuel Galimard, Giorgio Ottaviano, Anna Alonso-Saladrigues, Shatha Farhan, Sowjanya Vuyyala, Eva Michel, Fizza Imran, Nazaret Sánchez-Sierra, Nuria Martínez-Cibrian, Samppa Johannes Ryhänen, Richard Mitchell, Stephan Mielke, Soeren Lykke Petersen, Anne-Charlotte Teyssier, Thomas Pabst, Jürgen Kuball, Pere Barba, Antonio Pérez-Martínez, Andishe Attarbaschi, Arnon Nagler, José Antonio Pérez-Simón, Malte von Bonin, Emma K Nicholson, David Beauvais, Federica Sorà, Muriel Paganessi, Olaf Penack, Cristina Castilla-Llorente, Yves Beguin, Julio Delgado, Susana Rives, Krzysztof Kalwak, Fabio Ciceri, Annalisa Ruggeri, Adriana Cristina Balduzzi, and Sebastian Giebel
Vorinostat for graft-versus-host disease prevention in pediatric and young adult patients with hematologic malignancies, Nicolas Parnell, Xiao Cao, Jan H Beumer, Thomas M Braun, Yilei Cui, Gary J Fisher, Guoqing Hou, Julianne Holleran, Tracey Churay, Michelle Rozwadowski, Luna Heider, Mark T Vander Lugt, Carrie L Kitko, April L Rahrig, Edward Peres, Kirsten M Williams, Julie-An Talano, Vanessa A Fabrizio, Ghada Abusin, Gregory A Yanik, John Magenau, Mary Riwes, Marcus J Geer, Sarah Anand, Monalisa Ghosh, Attaphol Pawarode, Kristen Votruba, Pavan Reddy, and Sung Won Choi
Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE), Francesco Passamonti, James M Foran, Anand Tandra, Valerio De Stefano, Maria Laura Fox, Ahmad Mattour, Mary Frances McMullin, Andrew C Perkins, Gabriela Rodriguez-Macías, Hassan A Sibai, Akshanth R Polepally, Yan Sun, Avijeet S Chopra, Jason G Harb, Qin Qin, Jalaja Potluri, and Jonathan How
Clinical overview of trophoblast surface antigen 2 antibody-drug conjugates in non-small cell lung cancer, Sandip Pravin Patel, Shirish M. Gadgeel, Mari Mino-Kenudson, Jarushka Naidoo, and Nan Sethakorn
Histoprotective and antiproliferative effects of Raloxifene treatment during prostate carcinogenesis in rats, Cristiane Figueiredo Pinho, Liara Botão da Silva Soares, Júlia Landeira Gomez Chamelete, Giovanna Cassone Salata, Ariana Musa de Aquino, André Teves Aquino Gonçalves de Freitas, Sergio Pereira, Leonardo de Oliveira Mendes, and Wellerson Rodrigo Scarano
Impact of Socioeconomic Status on Patient-Reported Outcomes (PROs) in Non-Small-Cell Lung Cancer (NSCLC), Bindu Potugari, Jaya Gupta, Julia Bachler, Anqi Wang, Eric Adjei Boakye, Samantha Tam, Theresa Zatirka, Benjamin Movsas, and Shirish M. Gadgeel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0, Sonam Puri, Natasha B Leighl, Nofisat Ismaila, Fawzi Abu Rous, Amith Ahluwalia, Krishna Alluri, Ibrahim Hanna Azar, Toby Campbell, Greg Durm, Jill Feldman, Narjust Florez, Janet Freeman-Daily, Naoki Furuya, Shirish M. Gadgeel, Balazs Halmos, Hidehito Horinouchi, Sara Kuruvilla, Gary R Macvicar, Narinder Malhotra, Kristen Ashley Marrone, Deebya Raj Mishra, Michael Mullane, Jarushka Naidoo, Dwight H Owen, Bruna Pellini, Carolyn J Presley, Angel Qin, Logan Roof, Erin L Schenk, Lecia Sequist, Navneet Singh, Eric K Singhi, Jennifer Marie Suga, Ana I Velazquez, Yubao Wang, Paul Wheatley Price, Joshua E Reuss, and Lyudmila Bazhenova
Real-World Experience Using the Clinical Treatment Score at 5 Years (CTS5) and Breast Cancer Index (BCI) to Guide Extended Adjuvant Endocrine Therapy, Mohammad H. Qarmout, Yasir Alsaraf, Qasim M. Alameri, Grace Brannan, and Susan Lyons
NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions, Megan D Radyk, Barbara S Nelson, Mariana Tannus Ruckert, Christopher J Halbrook, Mengrou Shan, Jonathan M Alektiar, Brooke L Lavoie, Lucie Salvatore, Wei Yan, Matthew D Perricone, Kathryn Buscher, Alexander Wood, Hanna S Hong, Peter Sajjakulnukit, Li Zhang, Gabriel Corfas, Filip Bednar, Timothy L Frankel, Marina Pasca di Magliano, Justin A Colacino, Yatrik M Shah, Howard C. Crawford, and Costas A Lyssiotis
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0, Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila, Fawzi Abu Rous, Amith Ahluwalia, Krishna Alluri, Ibrahim Hanna Azar, Toby Campbell, Greg Durm, Jill Feldman, Narjust Florez, Janet Freeman-Daily, Naoki Furuya, Shirish M. Gadgeel, Balazs Halmos, Hidehito Horinouchi, Sara Kuruvilla, Gary R Macvicar, Narinder Malhotra, Kristen Ashley Marrone, Deebya Raj Mishra, Michael Mullane, Jarushka Naidoo, Dwight H Owen, Bruna Pellini, Carolyn J Presley, Angel Qin, Logan Roof, Erin L Schenk, Lecia Sequist, Navneet Singh, Eric K Singhi, Jennifer Marie Suga, Ana I Velazquez, Yubao Wang, Paul Wheatley Price, Sonam Puri, and Natasha B Leighl
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1, Joshua E Reuss, Nofisat Ismaila, Amith Ahluwalia, Toby Campbell, Jill Feldman, Shirish M. Gadgeel, Michael Mullane, Carolyn J Presley, Eric K Singhi, Jennifer Marie Suga, and Sonam Puri
All-cause mortality by race and socioeconomic status among women treated for breast cancer in metropolitan Detroit, Shaveena Sivapalan, Paul J. Chuba, Susan M. Szpunar, Khalid Berdi, Carrie L. Dul, Jeffrey S. Falk, and Amr M. Aref
Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients, Alexandra T. Skowron, Karen Childers, Courtney M. Rose, Kyle C. McElyea, Avery K. Supernois, Yousuf Hussain, Mohammed Baseer, Sunita Ghosh, and Clara Hwang
Sublingual Administration of All-Trans Retinoic Acid in Two Patients With Acute Promyelocytic Leukemia and Previous Gastric Bypass: A Case Series, Samuel Srinivasan, Rand Al-Adayleh, Zeinab Nasser, and Vijayalakshmi Donthireddy
Nodular Vasculitis Following Aromatase Inhibitor Therapy for Breast Cancer: A Case Report, Samuel Srinivasan, Maria Jamil, Sarine Tahmazian, Javairia Jamil, and Hiba Jabbour-Aida
Kaposi Sarcoma in an Allograft Kidney Presenting as Acute Kidney Injury With No Cutaneous Lesions: A Case Report, Samuel Srinivasan, Sarine Tahmazian, Bipin Ghimire, and Rebecca Chacko
Superior Sagittal Sinus Filling Defect in Metastatic Lung Cancer: Tumour Thrombus, Bland Thrombus or Both?, Haseeb K. Tareen, Mohammad H. Qarmout, Sharvana Aryal, Jody Zak, Haris Bin Tahir, Hafsa Ahmed, and Adam Forman
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors, David M Thomas, Jeong Eun Kim, Fabrice Barlesi, Uwe M Martens, Maciej Krzakowski, Rafal Dziadziuszko, Jae Ho Jeong, Gennaro Daniele, Timothy R Wilson, Felice Wu, Brian P Simmons, Sid Patel, Maria Sbirnac, Monika Kaul, and Shirish M. Gadgeel
Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways, Md Hafiz Uddin, Zaid Mahdi, Irfana Muqbil, Brendon R Herring, Bart Rose, Husain Y Khan, Yiwei Li, Amro Aboukameel, Sahar F Bannoura, Hugo Jimenez, Allan M Johansen, Mohammed Najeeb Al-Hallak, Ibrahim Azar, Amr Mohamed, Tarik Hadid, Nitin Vaishampayan, Yang Shi, Yin Wan, Vy Ong, Gregory Dyson, Rafic Beydoun, Miguel Tobon, Eliza W Beal, Herbert Chen, Anthony F Shields, Philip A. Philip, Jennifer Beebe-Dimmer, Ramzi M Mohammad, Boris C Pasche, Bassel F El-Rayes, and Asfar S Azmi
Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant, Kristen L Votruba, Michelle Rozwadowski, Thomas Braun, April Rahrig, Edward Peres, Kirsten M Williams, Vanessa Fabrizio, Julie-An Talano, Carrie L Kitko, Nicolas Parnell, Pavan Reddy, and Sung Won Choi
Updates in the Management of EGFR-Mutated Non-small Cell Lung Cancer (NSCLC), Abhinav Vyas, Won Jin Jeon, Sanad Alhushki, Eric Singhi, Fawzi Abu Rous, Rajat Thawani, and Aakash Desai
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium, Sarah Waliany, Alissa J Cooper, Stephen V Liu, Oliver Gautschi, Julia K Rotow, Katherine Emilie Rhoades Smith, Urs M Weber, Dae Ho Lee, Herbert H F Loong, Jyoti D Patel, Nathan A Pennell, Misako Nagasaka, Shetal A Patel, Daniel S W Tan, Benjamin J Solomon, Tae Min Kim, Georg Pall, Jonathan W Riess, Lova Sun, Martin Früh, Natalie F Uy, Shirish M. Gadgeel, Jamie Feng, Andrew Do, Christina Falcon, Natasha B Leighl, Christina S Baik, Gillianne G Y Lai, S Ignatius Ou, Kingsley S Y Cheung, Tejas Patil, Aaron S Mansfield, Daniela Weiler, Beow Y Yeap, Lori J Wirth, Justin F Gainor, Alexander Drilon, and Jessica J Lin
Multi-omics profiling of pancreatic neuroendocrine tumors: Interplay of genomic instability and the tumor microenvironment (Review), Yin Wan, Yingnan Zhang, Philip A. Philip, Herbert Chen, Bassel El-Rayes, Asfar S Azmi, and Yang Shi
Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantation, Erik J Woods, Sagar Munjal, Muneer H. Abidi, Jeremy Pantin, Vicki L Graves, Hans Nowak, Nicholas Weinstein, Kevin Blankenberger, Kelsey Musall, Preethi Prasad, W Scott Goebel, and Brian H Johnstone
Submissions from 2025
White Blood Counts of Hospitalized Patients Without Infection, Malignancy, or Immune Dysfunction, Yazan Abu Omar, Erin Sullivan, Rebecca Schulte, Rayli Pichardo, and Michael B Rothberg
SPACE: Spatially variable gene clustering adjusting for cell type effect for improved spatial domain detection, Sikta Das Adhikari, Nina G. Steele, Brian K. Theisen, Jianrong Wang, and Yuehua Cui
A Scoping Review on Barriers to Cancer Diagnosis and Care in Low- and Middle-Income Countries, Kwabena Agbedinu, Sylvester Antwi, Livingstone Aduse-Poku, Patrick Kafui Akakpo, Harriet Larrious-Lartey, Valerie Ofori Aboah, Samuel Mensah, Veneranda Nyarko, Forster Amponsah-Manu, Josephine Nsaful, Rose Dampson, Michael Nortey, Ijeoma Aja, Mohammed Sheriff, Moses Abdulai Dokurugu, Nelson Affram, Alex Mremi, Theresia Mwakyembe, Moses Kamita, Linda M. Kaljee, and Evelyn M. Jiagge
Interventions influencing patient-reported outcomes (PROs) response rates in cancer: a scoping review, Nada Al-Antary, Samantha Tam, Suma Alzouhayli, Theresa M. Zatirka, Michael Ryan, Steven S. Chang, Benjamin Movsas, and Eric Adjei Boakye
Is Shorter Better in Oncology Patients, Too? A Retrospective Cohort Study of Short- Versus Long-Course Antibiotic Therapy for Uncomplicated Infections in Solid Tumor Patients Receiving Care in Ambulatory Oncology Clinics, Christen J. Arena, Beisan El-Tatari, Kristen Lovric, Sage B. Greenlee, Rachel M. Kenney, Shirish M. Gadgeel, Katelyn M. Patterson, Anita B. Shallal, George J. Alangaden, Susan L. Davis, and Michael P. Veve
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations, Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura, Nishant Gandhi, Md Hafiz Uddin, Misako Nagasaka, Jun Gong, Bassel Nazha, Khalil Choucair, Nikhil Vojjala, Moh'd M Khushman, Heloisa P Soares, Wafik S El-Deiry, Philip A. Philip, Bassel El-Rayes, Herbert Chen, Emil Lou, Irfana Muqbil, Alex Patrick Farrell, Jeffrey Swensen, Matthew James Oberley, Chadi Nabhan, Sanjay Goel, Anthony F Shields, Ramzi M Mohammad, Boris C Pasche, and Asfar S Azmi
Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study, Hani M Babiker, Vincent Picozzi, Sreenivasa R Chandana, Bohuslav Melichar, Anup Kasi, Jin Gang, Javier Gallego, Andrea Bullock, Hao Chunyi, Lucjan Wyrwicz, Erika Hitre, Arsen Osipov, Christelle de la Fouchardiere, Inmaculada Ales, Tomislav Dragovich, Woojin Lee, Kynan Feeney, Philip A. Philip, Makoto Ueno, Eric Van Cutsem, Thomas Seufferlein, and Teresa Macarulla
Increasing Olanzapine Prescribing for Patients Undergoing Highly Emetogenic Chemotherapy, Ashley M Bowen, Aimee Cloud, Suzanne Fadly, Ryan Gennette, Zachary Hector-Word, JoAnn Hirth, Yelena Kier, Diana Kostoff, Philip Kuriakose, Binu Malhotra, Houman Nourkeyhani, Jatin Rana, Keli DeVries, Emily Mackler, Shawn Winsted, Eric Voisine, and Jennifer J Griggs
Safety of tarlatamab with 6-8-h outpatient versus 48-h inpatient monitoring during cycle 1: DeLLphi-300 phase 1 substudy, A C Chiang, M E Olmedo Garcia, J W Carlisle, A Dowlati, N Reguart, E Felip, P J Jost, N Steeghs, R Stec, Shirish M. Gadgeel, H H Loong, W Jiang, A Hamidi, A Parkes, and L Paz-Ares
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges, Khalil Choucair, Hafsa Imtiaz, Md Hafiz Uddin, Misako Nagasaka, Mohammad Najeeb Al-Hallak, Philip A. Philip, Bassel El-Rayes, Boris C Pasche, and Asfar S Azmi
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma, Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani, Mark Bloomston, Vincent Chung, Efrat Dotan, Cristina R Ferrone, Patricia F Gambino, Ajit H Goenka, Karyn A Goodman, William A Hall, Jin He, Melissa E Hogg, Shiva Jayaraman, Avinash Kambadakone, Matthew H G Katz, Alok A Khorana, Andrew H Ko, Eugene J Koay, David A Kooby, Somashekar G Krishna, Liliana K Larsson, Richard T Lee, Anirban Maitra, Nader N Massarweh, Sameh Mikhail, Mahvish Muzaffar, Eileen M O'Reilly, Manisha Palta, Maria Q B Petzel, Philip A. Philip, Marsha Reyngold, Daniel Santa Mina, Davendra P S Sohal, Tilak K Sundaresan, Susan Tsai, Kea L Turner, Timothy J Vreeland, Steve Walston, M Kay Washington, Terence M Williams, Jennifer Y Wo, and Rebecca A Snyder
Dose-Dense Docetaxel and Radium-223 in Bone-Dominant Metastatic Castration-Resistant Prostate Cancer, Brendan Connell, Clara Hwang, Edmund Folefac, Christian Lawlor, Benjamin Koethe, and Paul Mathew
RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT, Zachariah DeFilipp, Hannah K Choe, Yvonne A Efebera, Ayman Saad, Shatha Farhan, Lazaros J Lekakis, Jean A Yared, Gary J Schiller, Markus Y Mapara, Amer Assal, Ted A Gooley, Jack D Bui, Dana D Lee, Hayley Lane, and Yi-Bin Chen
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAF(V600E)-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study, Alessandro Di Federico, Kaiwen Wang, Monica F Chen, Adam A Barsouk, Arianna Pagliaro, Lanyi N Chen, Francesca R Ogliari, Paul Stockhammer, Rajat Thawani, Shahm Raslan, Eleonora Gariazzo, Francesca Fusco, Grace M Hambelton, Fabrizio Citarella, David Meyer, Mihaela Aldea, Andrea De Giglio, Joao V Alessi, Federica Pecci, Francesco Gelsomino, Marcelo Corassa, Natalie I Vokes, Xinan Wang, Dario de Biase, Fawzi Abu Rous, Phurin Areesawangkit, Omar Elghawy, Alessio Cortellini, Giulio Metro, Roberto Ferrara, Mark M Awad, Aliyah Pabani, Joseph C Murray, Federico Cappuzzo, Marina C Garassino, Ibiayi Dagogo-Jack, Gregory Riely, Michael Grant, Benjamin O Herzberg, Andrea Ardizzoni, David Planchard, Bruce E Johnson, Corey J Langer, Michael Offin, Marcelo V Negrao, and Biagio Ricciuti
Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT, Shatha Farhan, Vanessa E Kennedy, Manuel R Espinoza-Gutarra, Hannah Lust, Maria Silvina Odstrcil Bobillo, Adam Yuh Lin, Rebecca L Olin, Richard J Lin, Kelly E Rentscher, Mallory R Taylor, Lathika Mohanraj, William A Wood, Hemant S Murthy, Nuasheen Ahmed, Amylou C Dueck, Rachel Phelan, Debra Lynch Kelly, Carrie Yuen, Pashna N Munshi, Hélène Schoemans, Betty K Hamilton, Catherine Lee, and Anthony D Sung
Plain language summary of first-line amivantamab-lazertinib in previously untreated high-risk EGFR-altered non-small-cell lung cancer in MARIPOSA, Enriqueta Felip, Byoung Chul Cho, Shun Lu, Mehmet Ali Nahit Şendur, Shirish M. Gadgeel, Seema Sethi, Joshua M Bauml, and Hidetoshi Hayashi
Real-world characteristics and survival outcomes of patients with metastatic ALK fusion-positive solid tumors treated with standard-of-care therapies, Shirish M. Gadgeel, Otto Fajardo, Fabrice Barlesi, Jeong Eun Kim, Razelle Kurzrock, David M Thomas, Ritika Jagtiani, Johannes Noe, Sven Schwemmers, and Christos Nikolaidis
Response to: Enhancing Clinical Practice: Critical Insights for Medical Workers in Applying Pembrolizumab for Metastatic NSCLC and Pembrolizumab, Chemotherapy and Metastatic Non-Small Cell Lung Cancer, Shirish M. Gadgeel, Erin Jensen, Mark Shamoun, and Kumar Rajagopalan
Calcinosis Cutis With Selective Fibroblast Growth Factor Receptor Inhibitors: A Case Report and Review of Literature, Bipin Ghimire, Dhairya Gor, Omar Abbas, and Maria Diab
TP53-Mutated Acute Myeloid Leukemia: Review of Treatment and Challenges, Bipin Ghimire, Markie Zimmer, and Vijayalakshmi Donthireddy
Cutaneous Metastases Without a Known Primary: A Clinical Conundrum, Dhairya Gor, Bipin Ghimire, Omar Abbas, and Maria Diab
Protocol for a multisite, parallel-group, randomized clinical trial comparing a brief tele-cognitive behavioral therapy intervention (BRIGHT) with attention control for the reduction of body image-related distress among head and neck cancer survivors, Evan M Graboyes, Stacey N Maurer, Emily Kistner-Griffin, Kent Armeson, Ella Starr, Taylor McLeod, Wendy E Balliet, Jacquelyn Doenges, Olga Slavin-Spenny, Jessica R Vanderlan, Andrew Day, Patrik Pipkorn, Sidharth V Puram, Samantha Tam, Kenneth J Ruggiero, and Katherine R Sterba
High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma, Emily Greene, Natalie K Horvat, Deon Bryant Doxie, Vaunita Cohen Parihar, Jayden Kim, Cameron J Herting, Erin E Grundy, Ayana T Ruffin, Alyssa M Krasinskas, Shishir K Maithel, Juan M Sarmiento, Mihir M Shah, Mohammad Y Zaidi, Maria Diab, Olatunji B Alese, Kavita Dhodapkar, Haydn T Kissick, Bassel F El-Rayes, Chrystal M Paulos, and Gregory B Lesinski
Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers, Radhika Gutta, Emily Teslow, Ellen Jaeger, Melissa C Stoppler, Calvin Chao, Fawzi Abu Rous, Bindu Potugari, and Shirish M. Gadgeel
The Effect of Oncoplastic Reduction Mammoplasty on the Incidence of Breast Lymphedema in Women Undergoing Breast Conservation Surgery, Andrew Hannoudi, Madeleine R. Gonte, Cara E. Cannella, Kinan Sawar, Summer S. Yono, Noah M. Atisha, Eleanor M. Walker, Jessica Bensenhaver, Maristella S. Evangelista, and Dunya M. Atisha
Efficacy of a Brief Cognitive Behavioral Treatment Across Body Image Distress Domains: Secondary Outcomes of the BRIGHT Randomized Clinical Trial, Haley Hullfish, Emily Kistner-Griffin, Stacey Maurer, Wendy Balliet, Jessica Vanderlan, Olga Slavin-Spenny, Lynne Padgett, Angie Rush, Brad Johnson, Taylor McLeod, Ella J Starr, Kenneth J Ruggiero, Katherine R Sterba, and Evan M Graboyes
Infusion Reactions with Alternative Therapies During the National Shortage of Iron Dextran, Brigid Jacob, Maria Jamil, Shahm Raslan, Kylie Springer, Zeinab Nasser, and Philip Kuriakose
Five Data-Informed Principles for Advancing Inclusive Research in Clinical Trials: A Pharma Perspective, Spencer L James, Shalini Hede, Altovise T Ewing-Crawford, Ruma Bhagat, Nicole Richie, Mitchell D'Rozario, Pierre Theodore, Bea Lavery, Sarah Bentouati, Assaf P Oron, Catherine W Gillespie, Cleo A Ryals, Megan H Bair-Merritt, Johanna Chesley, Evelyn M. Jiagge, and Bruno Jolain
Single-Arm Investigator-Initiated Clinical Trial to Improve Germline Testing in At-Risk Patients With Prostate Cancer (IMPRINT), Juan Javier-DesLoges, Ana Flores Pimentel, Samuel Pena, Yasoda Satpathy, Yu-Wei Chen, Michael James Randall, Tyler Stewart, Christopher J Kane, Aditya Bagrodia, Clara Hwang, Lin Lu, Matthew Savage, Lisa Madlensky, and Rana R McKay
Cancer clinical trial participation: a qualitative study of Black/African American communities' and patient/survivors' recommendations, Linda M. Kaljee, Sylvester Antwi, Doreen Dankerlui, Donna Harris, Barbara Israel, Denise White-Perkins, Valerie Ofori Aboah, Livingstone Aduse-Poku, Harriet Larrious-Lartey, Barbara Brush, Chris Coombe, La'Toshia Patman, Nayomi Cawthorne, Sophia Chue, Zachary Rowe, Cassandra Mills, Kurt Fernando, Gwendolyn Daniels, Eleanor M. Walker, and Evelyn M. Jiagge
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy, Vanessa E Kennedy, Nausheen Ahmed, Andy Artz, Neel S Bhatt, Rachel Custatis, Manuel R Espinoza-Gutarra, Shatha Farhan, Robert J Ferguson, Betty Hamilton, Hannah Katz, Debra L Kelly, Jennifer M Knight, Catherine Lee, Adam Lin, Richard Lin, Lathika Mohanraj, Pashna Munshi, Mariam Nawas, Ashley M Nelson, Silvina Odstracil, Rebecca Olin, Rachel Phelan, Kelly E Rentscher, Hélène Schoemans, Anthony Sung, Mallory R Taylor, Wiliam Wood, Carrie H Yuen, and Reena V Jayani-Kosarzycki
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer, Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto, Ye Yao, Clara Hwang, Pedro C Barata, Mehmet Asim Bilen, Laura Graham, Rohan Garje, Shoshana Rothstein, Shabi Haider, Joseph J Park, Ruben Raychaudhuri, Amanda Pilling, Erica Chin, Vadim S Koshkin, Abhishek Tripathi, Frank Cameron Cackowski, Jones T Nauseef, Alexandra Sokolova, Adanma Ayanambakkam, Yousef Zakharia, Michael Thomas Schweizer, Andrew J Armstrong, Tanya B Dorff, Zachery Roger Reichert, and Rana R McKay
Small Cell Lung Cancer With de novo BRAF V600E Mutation and Durable Response to Targeted Therapy: A Case Report, Radhika Kulkarni, Elias Zeine, Bindu Potugari, Shirish M. Gadgeel, Joseph Montecalvo, and Fawzi Abu Rous
Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS), Ishmael Kyei, Vivian J Bea, Kofi K Gyan, Ernest Adjei, Brian Stonaker, Mahteme Bekele, Engida Abebe, Melissa Davis, Andrew Boakye, Richard Boateng, Olivier Elemento, Frances Aitpillah, Hanan Alebachew, Aisha Jibril, Yalei Chen, Evelyn Taiwo, Jessica Bensenhaver, Eleanor Walker, Haythem Y. Ali, Joseph Oppong, Paula Ginter, Hawa Nalwoga, Sam Kalungi, Godwin Ebughe, Emmanuel R Ezeome, Karen Jackson, Ernest Osei Bonsu, Adeyiza Momoh, Rachel Martini, Sandra Demaria, Clayton Yates, Onyinye D Balogun, Christopher Louie, Jyothi Manohar, Yaw Bediako, Gloria Agyekum Boaitey, Linda Ahenkorah Fondjo, Nneka Iloanusi, Ifeoma Okoye, Michael Adinku, Kwasi Ankomah, Charles Dally, Emily Rockefeller, Laura L. Susick, Ima Obong-Ekanem, Benjamin C Greenspun, Shimelis Abegaz Daba, Theresa Schwartz, Nicolas Robine, Shuibing Chen, Jian Carrot-Zhang, Setor Amazu, Evelyn M. Jiagge, Osei Kareem Acheamfour, Stevens Patino, Manmeet Malik, Tammy Ju, Beth Siegel, Iman Khalifa Martin, Cassandra Mills, Jocelyn Phillip, Chima Onwuka Kalu, Christine Joseph, Favour Peters, Amanda Stromain, Bankole Olusina, Onyekachi Nwokoro, Nwamaka Lasebikan, Joseph Udosen, Victor Nwagbara, John Carpten, Senait Fisseha, Timothy Johnson, Baffour Awuah, and Lisa A Newman
A Response to the Letter to the Editor: "Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?", Vincent K Lam and Shirish M. Gadgeel
Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC, Vincent K Lam and Shirish M. Gadgeel
Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (PE) alone or in combination with nivolumab as frontline therapy for extensive-stage small cell lung cancer (ES-SCLC): ECOG-ACRIN EA5161, Ticiana A Leal, Yating Wang, Afshin Dowlati, Christopher H Chay, Yuanbin Chen, Amit R. Mohindra, Mohammad Razaq, Harish G Ajuja, Jijun Liu, David M King, Christopher J Sumey, and Suresh S Ramalingam
